Immune Checkpoint Inhibitor Metastatic NSCLC: Combination Strategies - Episode 6

Chemoimmunotherapy in mNSCLC: Design and Outcomes of the POSEIDON Trial

A key opinion leader reviews the study design and efficacy and safety outcomes of the POSEIDON trial investigating durvalumab + tremelimumab + chemotherapy for treatment of mNSCLC.